The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 148,844 | 144,254 | 369,138 | - |
| Depreciation and amortization | 127,344 | 125,818 | 378,523 | - |
| Noncash amortization of deferred financing costs, debt discounts and cash flow hedging instruments | 2,408 | 2,421 | 7,618 | - |
| Noncash share-based compensation | 6,760 | 5,456 | 20,359 | - |
| Loss on early extinguishment of debt | 0 | 0 | -396 | - |
| Equity in net loss of unconsolidated entities | -1,192 | 290 | 30 | - |
| Return on investment from unconsolidated joint ventures | 0 | 670 | 2,959 | - |
| Gain on sale and impairment of single-family properties and other, net | 78,444 | 69,916 | 161,544 | - |
| Rent and other receivables | 5,334 | -11,786 | 10,473 | - |
| Prepaid expenses and other assets | 5,926 | -2,352 | -19,603 | - |
| Deferred leasing costs | 627 | 521 | 3,102 | - |
| Accounts payable and accrued expenses | 9,961 | -75,850 | 94,010 | - |
| Amounts due from related parties | 3,118 | 368 | -1,058 | - |
| Net cash provided by operating activities | 203,060 | 145,812 | 718,515 | - |
| Cash paid for single-family properties | 0 | 4,558 | 19,029 | - |
| Change in escrow deposits for purchase of single-family properties and land | 968 | -644 | 3,139 | - |
| Net proceeds received from sales of single-family properties and other | 198,443 | 208,114 | 422,238 | - |
| Proceeds received from storm-related insurance claims | 212 | 1,588 | 2,432 | - |
| Proceeds from notes receivable related to the sale of properties | 59 | 0 | 215 | - |
| Investment in unconsolidated joint ventures | 4,771 | 2,500 | 12,578 | - |
| Distributions from unconsolidated entities | 2,812 | 14,846 | 63,856 | - |
| Renovations to single-family properties | 9,409 | 10,347 | 30,298 | - |
| Recurring and other capital expenditures for single-family properties | 23,218 | 24,377 | 93,834 | - |
| Cash paid for development activity | 145,523 | 222,651 | 587,856 | - |
| Cash paid for deposits on land option contracts | - | 0 | 0 | - |
| Proceeds from asset-backed securitization certificates | - | 0 | 0 | - |
| Other investing activities | 7,383 | 8,295 | 22,638 | - |
| Net cash provided by (used for) investing activities | 10,254 | -47,536 | -280,631 | - |
| Proceeds from issuance of class a common shares-Common Class A | - | 0 | 0 | - |
| Payments of class a common share issuance costs-Common Class A | - | 0 | 0 | - |
| Repurchases of class a common shares-Common Class A | 115,144 | 150,093 | - | - |
| Proceeds from issuances under share-based compensation plans | 388 | 1,988 | 4,078 | - |
| Payments related to tax withholding for share-based compensation | 9,639 | 21 | 11,830 | - |
| Payments on asset-backed securitizations | 0 | 0 | 925,787 | - |
| Proceeds from revolving credit facility-Revolving Credit Facility | 30,000 | 250,000 | 520,000 | - |
| Payments on revolving credit facility-Revolving Credit Facility | - | 0 | 410,000 | - |
| Proceeds from unsecured senior notes, net of discount | - | 0 | 646,385 | - |
| Settlement of cash flow hedging instruments | - | 0 | -31 | - |
| Payments related to liabilities to repurchase consolidated land not owned | 0 | 15,862 | 38,174 | - |
| Distributions to noncontrolling interests | 16,505 | 15,182 | 45,790 | - |
| Distributions to common shareholders | 121,454 | 110,665 | 335,627 | - |
| Distributions to preferred shareholders | 3,486 | 3,486 | 10,458 | - |
| Deferred financing costs paid | - | 0 | 5,193 | - |
| Net cash used for financing activities | -235,840 | -43,321 | -612,365 | - |
| Net decrease in cash, cash equivalents and restricted cash | -22,526 | 54,955 | -174,481 | - |
| Cash, cash equivalents and restricted cash, beginning of period (see note 3) | 175,735 | - | 350,216 | - |
| Net increase in cash, cash equivalents and restricted cash | - | - | - | 116,384 |
| Cash, cash equivalents and restricted cash, end of period (see note 3) | 208,164 | - | 175,735 | - |
American Homes 4 Rent (AMH)
American Homes 4 Rent (AMH)